| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $4.99M | - | |
| Other | 21.6K | $1.42M | - | |
| Other | 15.4K | $1.01M | -5,538 | |
| Dir | 8.0K | $525.6K | - | |
| Dir | 8.0K | $525.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 | Robin Howard W58 | President &CEO | Sell | 19,635 | $3.00 | $58,905.00 | -2.0% | -76.5% | -76.1% | |
| Nov 16, 2022 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 13,460 | $3.57 | $48,052.20 | -4.1% | -14.2% | -85.7% | |
| Nov 16, 2022 | Thomsen Jillian B.86 | Chief Financial Officer | Sell | 11,095 | $3.57 | $39,609.15 | -3.3% | -14.2% | -85.7% | |
| Nov 16, 2022 | Wilson Mark Andrew58 | Chief Legal Officer | Sell | 8,690 | $3.57 | $31,023.30 | -3.1% | -14.2% | -85.7% | |
| Nov 16, 2022 | Robin Howard W58 | President &CEO | Sell | 38,014 | $3.57 | $135,709.98 | -3.7% | -14.2% | -85.7% | |
| Sep 23, 2022 | Curet Myriam56 | Director | Sell | 4,198 | $3.16 | $13,265.68 | -11.7% | -26.8% | -80.4% | |
| Sep 23, 2022 | Ajer Jeffrey Robert58 | Director | Sell | 4,198 | $3.16 | $13,265.68 | -9.8% | -26.8% | -80.4% | |
| Sep 22, 2022 | Chess Robert84 | Director | Sell | 10,200 | $0.67 | $6,834.00 | -3.6% | -23.0% | -80.9% | |
| Sep 22, 2022 | Chess Robert84 | Director | Sell | 5,100 | $3.19 | $16,269.00 | -2.2% | -23.0% | -80.9% | |
| Sep 13, 2022 | Eastham Karin65 | Director | Sell | 21,267 | $3.61 | $76,773.87 | -62.0% | -23.7% | -80.6% |